MedPath

A feasibility study of Risk-Reducing Salpingo-Oophorectomy based on hereditary breast and ovarian cancer syndrome -associated gene mutations

Not Applicable
Recruiting
Conditions
Patients with mutations in BRCA1/2, BRIP, RAD51C and RAD51D genes
Registration Number
JPRN-UMIN000044616
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who do not have sufficient judgment, are unconscious, or require consideration of the name of the disease (2) Patients with serious life-threatening complications. (3) Patients who are judged by the principal investigator to be inappropriate for inclusion in the study. (4) Patients whose consent has not been obtained or who have requested to withdraw their consent. (5) Any other patient whom the principal investigator or sub-investigator deems inappropriate to conduct this research.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ong-term prognosis (incidence of peritoneal cancer, postoperative survival, cause of death, etc.)
Secondary Outcome Measures
NameTimeMethod
a) Safety of the surgery (considerations associated with RRSO, etc.) b) Onset of adverse events after surgery (other morbidity and mortality such as cardiovascular disease, artificial menopause, osteoporosis, unexpected complications, etc.) c) Quality of life after surgery d) Pathological examination of the removed bilateral ovaries, fallopian tubes (and uterus) (preparation of whole area histological sections)
© Copyright 2025. All Rights Reserved by MedPath